T-cell receptor recognizing HIV-1 Env-derived peptides presented on MHC (HIV-1 Env-specific TCR)

The T-cell receptor (TCR) recognizing HIV-1 Env-derived peptides presented on MHC is a specialized immune protein complex found on the surface of T lymphocytes. Its primary biological function is the highly specific recognition of viral antigens, specifically peptides derived from the HIV-1 Envelope (Env) glycoproteins (gp120 and gp41), which are processed and displayed by Major Histocompatibility Complex (MHC) molecules on infected host cells. Upon binding to these peptide-MHC complexes, the TCR initiates intracellular signaling pathways that lead to T-cell activation, the release of cytotoxic granules (like perforin and granzymes), and the secretion of pro-inflammatory cytokines to eliminate the virus-producing cells. In the context of HIV-1 infection, natural TCR responses are often insufficient to clear the virus due to rapid viral mutation and immune exhaustion. Consequently, this TCR is a major focus of therapeutic development, particularly in TCR-engineered T-cell (TCR-T) therapies and bispecific T-cell engagers. These strategies aim to redirect the patient's immune system to recognize conserved Env epitopes, potentially providing a functional cure or long-term viral suppression by targeting the latent or active viral reservoir.

Other names

HIV-1 Envelope-specific T-cell receptorgp120-specific T-cell receptorgp41-specific T-cell receptorHIV-1 Env-MHC specific TCRAnti-HIV-1 Env TCR

Engineered T-cells or bispecific molecules utilize the TCR to specifically bind HIV-1 Envelope protein fragments (peptides) presented by Major Histocompatibility Complex (MHC) molecules on the surface of infected cells, triggering targeted cell lysis and viral clearance.